BioCentury
ARTICLE | Company News

Bio-Rad Laboratories, Saigene sales and marketing update

May 3, 1999 7:00 AM UTC

Bio-Rad received an exclusive worldwide license to commercialize Saigene's genetic markers associated with Type I (insulin-dependent) diabetes. ...